Loading recalls…
Loading…
Loading…
Home › All recalls › Prescription medicine
Category
Prescription drugs recalled for contamination, potency or labelling.
Or try another category
2,102 recalls · newest first
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
CGMP Deviations: product manufactured in the same facility under the same conditions as the product found to be contaminated
CGMP Deviations; product manufactured in the same facility under the same conditions as the product found to be contaminated
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
Failed PH Specifications
This recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side.
Lack of Assurance of Sterility: Potential leaks from perforations in bags.
Lack of Assurance of Sterility: Potential leaks from perforations in bags.
Failed Impurities/Degradation Specifications: Out of specification for specific impurity Tretinoin
Lack of Assurance of Sterility
Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.
Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.
Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.
cGMP deviations.
cGMP deviations.